Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer

Archives of Internal Medicine

Volumn 160, Issue 3, 2000, Pages 349-353

  Meier, Christoph R ^a,b   Derby, Laura E ^a   Jick, Susan S ^a   Jick, Hershel ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; VERAPAMIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DATA BASE; DRUG USE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING;

EID: 0034645944     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.3.349     Document Type: Article

References (22)

1. Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-l-converting enzyme protect against risk of cancer? Lancet. 1998;352:179-184.
2. Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens. 1996;9:695-699.
3. Pahor M, Guralnik JM, Ferrucci L, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet. 1996;348:493-497.
4. Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer. 1997;80:1438-1447.
5. Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, Meier CR. Calcium-channel blockers and risk of cancer. Lancet. 1997;349:525-528.
6. Rosenberg L, Rao RS, Palmer JR, et al. Calcium channel blockers and the risk of cancer. JAMA. 1998;279:1000-1004.
7. Olsen JH, Toft Sorensen HT, Friis S, et al. Cancer risk in users of calcium channel blockers. Hypertension. 1997;29:1091-1094.
8. Jonas M, Goldbourt U, Boyko V, Mandelzweig L, Behar S, Reicher-Reiss H. Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction. Cardiovasc Drugs Ther. 1998;12:177-181.
9. Braun S, Boyko V, Behar S, et al. Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11575 patients. J Am Coll Cardiol. 1996;28:7-11.
10. The effect of diltiazem on mortality and reinfarction after myocardial infarction: the Multicenter Diltiazem Postinfarction Trial Research Group. N Engl J Med. 1988; 319:385-392.
11. Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens. 1996;14:1237-1245.
12. Ahr HJ, Bomhard E, Mager H, Schlüter G. Calcium channel blockers and cancer: is there preclinical evidence for an association? Cardiology. 1997;88(suppl 3): 68-72.
13. Perry J, ed. OXMIS Problem Codes for Primary Medical Care. Oxford, England: OXMIS Publications; 1978.
14. Commission on Professional and Hospital Activities. H-ICDA, Hospital Adaptation of ICDA. 2nd ed. Ann Arbor, Mich: Commission on Professional and Hospital Activities; 1973.
15. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991; 302:766-768.
16. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Safety. 1992;1:347-349.
17. Walley T, Mantgani A. The UK General Practice Research Database. Lancet. 1997; 350:1097-1099.
18. Meier CR, Jick H. Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol. 1998;45:608-612.
19. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278:1407-1411.
20. Smith-Warner SA, Spiegelmann D, Yaun S-S, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998;279:535-540.
21. Bowlin SJ, Leske MC, Varma A, Nasca P, Weinstein A, Caplan L. Breast cancer risk and alcohol consumption: results from a large case-control study. Int J Epidemiol. 1997;26:915-923.
22. Bianchi S, Palli D, Galli M, Zampi G. Benign breast disease and cancer risk. Crit Rev Oncol Hematol. 1993;15:221-242.